Operant nociception in nonhuman primates

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Pain

• Publication date

  2014-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.pain.2014.06.010PMID 24968803PMCID PMC4157960
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Morphine- and buprenorphine-induced analgesia and antihyperalgesia in a human inflammatory pain model: a double-blind, randomized, placebo-controlled, five-arm crossover study

  2013cited by this paper
• Use of the Operant Orofacial Pain Assessment Device (OPAD) to measure changes in nociceptive behavior.

  2013cited by this paper
• Cannabinoid Discrimination and Antagonism by CB1 Neutral and Inverse Agonist Antagonists

  2013cited by this paper
• A novel touch-sensitive apparatus for behavioral studies in unrestrained squirrel monkeys.

  2012cited by this paper
• Current challenges in translational pain research.

  2012cited by this paper
• Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair

  2012cited by this paper
• Anxiolytic-like effect of central administration of NOP receptor antagonist UFP-101 in rats submitted to the elevated T-maze.

  2011cited by this paper
• Effect of caloric and non-caloric sweet reward solutions on thermal facial operant conditioning.

  2011cited by this paper
• Do Animal Models Tell Us about Human Pain ?

  2010cited by this paper
• The Development of New Analgesics Over the Past 50 Years: A Lack of Real Breakthrough Drugs

  2010cited by this paper
• Animal models of pain: progress and challenges

  2009cited by this paper
• Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys.

  2009cited by this paper
• Behavioral Effects of a Synthetic Agonist Selective for Nociceptin/Orphanin FQ Peptide Receptors in Monkeys

  2009cited by this paper
• Emerging strategies for exploiting cannabinoid receptor agonists as medicines

  2009cited by this paper
• Clinical and pre‐clinical pain assessment: Are we measuring the same thing?

  2008influential reference
• Opioid complications and side effects.

  2008cited by this paper
• The Anxiolytic-Like Effects of the Novel, Orally Active Nociceptin Opioid Receptor Agonist 8-[bis(2-Methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)

  2008cited by this paper
• Evaluation of prescription opioids using operant-based pain measures in rats.

  2008cited by this paper
• Time-dependent decreases in apparent pA2 values for naltrexone studied in combination with morphine in rhesus monkeys

  2007cited by this paper
• Characterization of cold sensitivity and thermal preference using an operant orofacial assay

  2006cited by this paper
• 75 years of opioid research: the exciting but vain quest for the Holy Grail

  2006cited by this paper
• Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity

  2005cited by this paper
• Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice.

  2005cited by this paper
• Nociceptin/Orphanin FQ Increases Anxiety-Related Behavior and Circulating Levels of Corticosterone During Neophobic Tests of Anxiety

  2004cited by this paper
• Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research

  2003cited by this paper
• Guidelines for the care and use of mammals in neuroscience and behavioral research

  2003cited by this paper
• Low dose systemic morphine attenuates operant escape but facilitates innate reflex responses to thermal stimulation.

  2002cited by this paper
• N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.

  2001cited by this paper
• Animal models of nociception.

  2001cited by this paper
• A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat.

  2000cited by this paper
• Discovery of the First Potent and Selective Small Molecule Opioid Receptor‐Like (ORL1) Antagonist: 1‐[(3R,4R)‐1‐Cyclooctylmethyl‐3‐hydroxymethyl‐4‐piperidyl] ‐3‐ethyl‐1,3‐diyhdro‐2H‐benzimidazol‐2‐one (J‐113397).

  2000cited by this paper
• Effects of Δ9-tetrahydrocannabinol, (R)-methanandamide, SR 141716, and d-amphetamine before and during daily Δ9-tetrahydrocannabinol dosing

  2000cited by this paper
• Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing.

  2000cited by this paper
• Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397).

  1999cited by this paper
• Clocinnamox Antagonism of the Antinociceptive Effects of Mu Opioids in Squirrel Monkeys 1

  1998cited by this paper
• Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.

  1998cited by this paper
• Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys.

  1998cited by this paper
• The Relationship Between Pain and Depression

  1996cited by this paper
• Effects of systemic morphine on responses of primates to first or second pain sensations

  1996cited by this paper
• Behavioral pharmacology of buprenorphine: issues relevant to its potential in treating drug abuse.

  1992cited by this paper
• Formalin pain is expressed in decerebrate rats but not attenuated by morphine

  1992cited by this paper
• Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.

  1991cited by this paper
• Measurement of pain and morphine hypalgesia in monkeys

  1986cited by this paper
• Discriminative-stimulus effects of midazolam in squirrel monkeys: comparison with other drugs and antagonism by Ro 15-1788.

  1985cited by this paper
• Effects of buprenorphine on shock titration in squirrel monkeys.

  1985cited by this paper
• Effects of morphine, pentazocine and cyclazocine alone and in combination with naloxone on electric shock titration in the squirrel monkey.

  1979cited by this paper
• A double-blind comparison of morphine and buprenorphine in the prevention of pain after operation.

  1978cited by this paper
• Buprenorphine: a new potent long-acting synthetic analgesic. Comparison with morphine.

  1977cited by this paper
• Rate-Dependency of the Behavioral Effects of Amphetamine

  1977cited by this paper
• What is analgesia

  1973cited by this paper

• Nociceptin/Orphanin FQ receptor agonism attenuates behavioral and neural responses to conditioned aversive stimuli

  2025cites this paper
• Determinants of drug effects in preclinical assays of pain-related behavioral depression: Considerations for analgesic drug development.

  2025cites this paper
• Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments

  2023cites this paper
• Nociceptin Receptor-Related Agonists as Safe and Non-addictive Analgesics

  2023cites this paper
• Challenges with Assessing and Treating Pain in Research Primates: A Focused Survey and Literature Review

  2022cites this paper
• Animal Models to Evaluate Expression, Mechanisms, and Treatment of Pain

  2021cites this paper
• Lack of effect of the nociceptin opioid peptide agonist Ro 64-6198 on pain-depressed behavior and heroin choice in rats.

  2021cites this paper
• Translational value of non-human primates in opioid research.

  2021cites this paper
• Effects of oxycodone and diazepam alone and in combination on operant nociception

  2020cites this paper
• Developing Improved Translational Models of Pain: A Role for the Behavioral Scientist

  2020cites this paper
• Nociceptin/orphanin FQ peptide receptor-related ligands as novel analgesics.

  2020cites this paper
• Effects of stimulation of mu opioid and nociceptin/orphanin FQ peptide (NOP) receptors on alcohol drinking in rhesus monkeys

  2019cites this paper
• Core Outcome Measures in Preclinical Assessment of Candidate Analgesics

  2019cites this paper
• Effects of NOP-Related Ligands in Nonhuman Primates.

  2019cites this paper
• Concurrent Assessment of the Antinociceptive and Behaviorally Disruptive Effects of Opioids in Squirrel Monkeys.

  2018cites this paper
• Evaluation of different drug classes on transient sciatic nerve injury–depressed marble burying in mice

  2018cites this paper
• Endogenous Opiates and Behavior: 2015.

  2017cites this paper
• Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility.

  2016cites this paper
• Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys

  2016cites this paper
• The pain of pain: challenges of animal behavior models.

  2015cites this paper